Low Serum Level of the Endogenous Secretory Receptor for Advanced Glycation End Products (esRAGE) Is a Risk Factor for Prevalent Vertebral Fractures Independent of Bone Mineral Density in Patients With Type 2 Diabetes

OBJECTIVE: Patients with type 2 diabetes are known to have an increased risk for fracture compared with non–type 2 diabetic control subjects, despite having higher bone mineral density (BMD). We previously showed that serum pentosidine, one of the advanced glycation end products (AGEs), was associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Masahiro, Yamaguchi, Toru, Yamauchi, Mika, Sugimoto, Toshitsugu
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782988/
https://www.ncbi.nlm.nih.gov/pubmed/19752174
http://dx.doi.org/10.2337/dc09-0901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782988/
https://www.ncbi.nlm.nih.gov/pubmed/19752174
http://dx.doi.org/10.2337/dc09-0901

Ejemplares similares